In vivo optical imaging correlates with improvement of cerebral ischemia treated by intravenous bone marrow stromal cells (BMSCs) and edaravone

Feng Feng Tian, Toru Yamashita, Kentaro Deguchi, Yoshio Omote, Hiromi Kawai, Yasuyuki Ohta, Koji Abe

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Recent studies show that modern in vivo optical imaging can detect matrix metallopeptidase (MMP) activation in the ischemic brain. In this study, we analyze the protective effects of bone marrow stromal cells (BMSCs) and edaravone (EDA) against tissue plasminogen activator (tPA) risk in the ischemic brain with in vivo optical fluorescence MMP imaging. Methods: At 48 hours after 60 minutes of transient middle cerebral artery occlusion (tMCAO) with tPA, C57BL/6J mice were subjected to motor function analysis, in vivo and ex vivo optical imaging for MMP activation, gelatin zymography, and double immunofluorescent analyses with or without intravenous BMSC transplantation and the intravenous free radical scavenger EDA. Results: In vivo fluorescent signals for MMP were detected over the heads of living mice 48 hours after tMCAO; the strongest were in the tPA group, which were reduced by BMSC or EDA treatment. These in vivo data were confirmed by ex vivo fluorescence imaging. While massive intracerebral hemorrhages were observed in the ischemic hemispheres of the tPA group, only slight hemorrhages were found in the tPA/ BMSC, tPA/EDA, and EDA groups. Gelatin zymography showed the strongest MMP-9 activation in the tPA group after tMCAO, which was reduced by BMSC or EDA treatment.Conclusion: The present study provides a correlation between in vivo optical imaging of MMP activation and the improvement of ischemic brain damage caused by tPA after tMCAO and treated by BMSC and EDA.

Original languageEnglish
Pages (from-to)1051-1058
Number of pages8
JournalNeurological Research
Volume35
Issue number10
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Optical Imaging
Tissue Plasminogen Activator
Brain Ischemia
Mesenchymal Stromal Cells
Metalloproteases
Middle Cerebral Artery Infarction
Gelatin
Brain
Free Radical Scavengers
phenylmethylpyrazolone
Cerebral Hemorrhage
Bone Marrow Transplantation
Inbred C57BL Mouse
Fluorescence
Head
Hemorrhage
Therapeutics

Keywords

  • BMSC
  • Edaravone
  • Ex vivo imaging
  • In vivo imaging
  • MMPs
  • tMCAO
  • tPA

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

In vivo optical imaging correlates with improvement of cerebral ischemia treated by intravenous bone marrow stromal cells (BMSCs) and edaravone. / Tian, Feng Feng; Yamashita, Toru; Deguchi, Kentaro; Omote, Yoshio; Kawai, Hiromi; Ohta, Yasuyuki; Abe, Koji.

In: Neurological Research, Vol. 35, No. 10, 12.2013, p. 1051-1058.

Research output: Contribution to journalArticle

@article{4f13a8e93d9a48569ac092062662ba40,
title = "In vivo optical imaging correlates with improvement of cerebral ischemia treated by intravenous bone marrow stromal cells (BMSCs) and edaravone",
abstract = "Objective: Recent studies show that modern in vivo optical imaging can detect matrix metallopeptidase (MMP) activation in the ischemic brain. In this study, we analyze the protective effects of bone marrow stromal cells (BMSCs) and edaravone (EDA) against tissue plasminogen activator (tPA) risk in the ischemic brain with in vivo optical fluorescence MMP imaging. Methods: At 48 hours after 60 minutes of transient middle cerebral artery occlusion (tMCAO) with tPA, C57BL/6J mice were subjected to motor function analysis, in vivo and ex vivo optical imaging for MMP activation, gelatin zymography, and double immunofluorescent analyses with or without intravenous BMSC transplantation and the intravenous free radical scavenger EDA. Results: In vivo fluorescent signals for MMP were detected over the heads of living mice 48 hours after tMCAO; the strongest were in the tPA group, which were reduced by BMSC or EDA treatment. These in vivo data were confirmed by ex vivo fluorescence imaging. While massive intracerebral hemorrhages were observed in the ischemic hemispheres of the tPA group, only slight hemorrhages were found in the tPA/ BMSC, tPA/EDA, and EDA groups. Gelatin zymography showed the strongest MMP-9 activation in the tPA group after tMCAO, which was reduced by BMSC or EDA treatment.Conclusion: The present study provides a correlation between in vivo optical imaging of MMP activation and the improvement of ischemic brain damage caused by tPA after tMCAO and treated by BMSC and EDA.",
keywords = "BMSC, Edaravone, Ex vivo imaging, In vivo imaging, MMPs, tMCAO, tPA",
author = "Tian, {Feng Feng} and Toru Yamashita and Kentaro Deguchi and Yoshio Omote and Hiromi Kawai and Yasuyuki Ohta and Koji Abe",
year = "2013",
month = "12",
doi = "10.1179/1743132813Y.0000000252",
language = "English",
volume = "35",
pages = "1051--1058",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "10",

}

TY - JOUR

T1 - In vivo optical imaging correlates with improvement of cerebral ischemia treated by intravenous bone marrow stromal cells (BMSCs) and edaravone

AU - Tian, Feng Feng

AU - Yamashita, Toru

AU - Deguchi, Kentaro

AU - Omote, Yoshio

AU - Kawai, Hiromi

AU - Ohta, Yasuyuki

AU - Abe, Koji

PY - 2013/12

Y1 - 2013/12

N2 - Objective: Recent studies show that modern in vivo optical imaging can detect matrix metallopeptidase (MMP) activation in the ischemic brain. In this study, we analyze the protective effects of bone marrow stromal cells (BMSCs) and edaravone (EDA) against tissue plasminogen activator (tPA) risk in the ischemic brain with in vivo optical fluorescence MMP imaging. Methods: At 48 hours after 60 minutes of transient middle cerebral artery occlusion (tMCAO) with tPA, C57BL/6J mice were subjected to motor function analysis, in vivo and ex vivo optical imaging for MMP activation, gelatin zymography, and double immunofluorescent analyses with or without intravenous BMSC transplantation and the intravenous free radical scavenger EDA. Results: In vivo fluorescent signals for MMP were detected over the heads of living mice 48 hours after tMCAO; the strongest were in the tPA group, which were reduced by BMSC or EDA treatment. These in vivo data were confirmed by ex vivo fluorescence imaging. While massive intracerebral hemorrhages were observed in the ischemic hemispheres of the tPA group, only slight hemorrhages were found in the tPA/ BMSC, tPA/EDA, and EDA groups. Gelatin zymography showed the strongest MMP-9 activation in the tPA group after tMCAO, which was reduced by BMSC or EDA treatment.Conclusion: The present study provides a correlation between in vivo optical imaging of MMP activation and the improvement of ischemic brain damage caused by tPA after tMCAO and treated by BMSC and EDA.

AB - Objective: Recent studies show that modern in vivo optical imaging can detect matrix metallopeptidase (MMP) activation in the ischemic brain. In this study, we analyze the protective effects of bone marrow stromal cells (BMSCs) and edaravone (EDA) against tissue plasminogen activator (tPA) risk in the ischemic brain with in vivo optical fluorescence MMP imaging. Methods: At 48 hours after 60 minutes of transient middle cerebral artery occlusion (tMCAO) with tPA, C57BL/6J mice were subjected to motor function analysis, in vivo and ex vivo optical imaging for MMP activation, gelatin zymography, and double immunofluorescent analyses with or without intravenous BMSC transplantation and the intravenous free radical scavenger EDA. Results: In vivo fluorescent signals for MMP were detected over the heads of living mice 48 hours after tMCAO; the strongest were in the tPA group, which were reduced by BMSC or EDA treatment. These in vivo data were confirmed by ex vivo fluorescence imaging. While massive intracerebral hemorrhages were observed in the ischemic hemispheres of the tPA group, only slight hemorrhages were found in the tPA/ BMSC, tPA/EDA, and EDA groups. Gelatin zymography showed the strongest MMP-9 activation in the tPA group after tMCAO, which was reduced by BMSC or EDA treatment.Conclusion: The present study provides a correlation between in vivo optical imaging of MMP activation and the improvement of ischemic brain damage caused by tPA after tMCAO and treated by BMSC and EDA.

KW - BMSC

KW - Edaravone

KW - Ex vivo imaging

KW - In vivo imaging

KW - MMPs

KW - tMCAO

KW - tPA

UR - http://www.scopus.com/inward/record.url?scp=84887580266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887580266&partnerID=8YFLogxK

U2 - 10.1179/1743132813Y.0000000252

DO - 10.1179/1743132813Y.0000000252

M3 - Article

VL - 35

SP - 1051

EP - 1058

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 10

ER -